FDA Approves Menactra for Infants from 9 Months

Menactra, a vaccine for the prevention of invasive meningococcal disease for children ages 9 months and older, has been approved by the U.S. Food and Drug Administration.

FDA Approves Shingles Vaccine for Ages 50-59

Zostavax, the vaccine manufactured by Merck & Co. to prevent shingles, has been approved by the U.S. Food and Drug Administration for adults ages 50 to 59 years old.

FDA Approves 60-Second HIV Test

The U.S. Food and Drug Administration has approved a single-use rapid test that detects antibodies to HIV-1 in as little as 60 seconds.

FDA Extends Shelf Life of Hizentra to 30 Months

The U.S.Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra.

FDA Approves First Drug to Treat Lupus

The U.S. Food and Drug Administration (FDA) has approved Benlysta (belimumab) to treat patients with active autoantibody positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives and non steroidal anti-inflammatory drugs.

FDA OKs Prolastin-C for AAT Deficiency

Prolastin-C has been approved by the Food and Drug Administration for the treatment of alpha1-antitrypsin (AAT)deficiency.

FDA Approves Drugs for HAE Treatment

The Food and Drug Administration has approved two new drugs for the treatment of acute attacks of hereditary angioedema.

FDA Approves Octapharma’s wilate

The U.S.Food and Drug Administration has approved wilate for the treatment of spontaneous and trauma-induced bleeding episodes in patients with all types of von Willebrand disease.